2010
DOI: 10.1016/j.neuroscience.2010.07.048
|View full text |Cite
|
Sign up to set email alerts
|

The protective effects of interleukin-18 and interferon-γ on neuronal damages in the rat hippocampus following status epilepticus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
21
0
2

Year Published

2010
2010
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(23 citation statements)
references
References 52 publications
0
21
0
2
Order By: Relevance
“…For example, type 1 interferons have been regarded as anti-inflammatory within the brain due to their ability to limit leukocyte infiltration (Prinz et al, 2008) and reduce expression of pro-inflammatory cytokines including IL-1β and TNFα (Teige et al, 2006). IFNγ has also been shown to elicit antiinflammatory effects (Muhl and Pfeilschifter, 2003), protect neurons from damage initiated by viral infection (Geiger et al, 1997;Rodriguez et al, 2003), protect cultured hippocampal neurons against glutamate-induced excitotoxic death (Lee et al, 2006) and alleviate status epilepticus-induced neuronal damage in the hippocampus of rats (Ryu et al, 2010). Furthermore, enhancement of both type 1 and 2 interferons limits inflammation and disease progression in models of multiple sclerosis (Lin et al, 2007;Bowen and Olson, 2013;Naves et al, 2013).…”
Section: Discussionmentioning
confidence: 99%
“…For example, type 1 interferons have been regarded as anti-inflammatory within the brain due to their ability to limit leukocyte infiltration (Prinz et al, 2008) and reduce expression of pro-inflammatory cytokines including IL-1β and TNFα (Teige et al, 2006). IFNγ has also been shown to elicit antiinflammatory effects (Muhl and Pfeilschifter, 2003), protect neurons from damage initiated by viral infection (Geiger et al, 1997;Rodriguez et al, 2003), protect cultured hippocampal neurons against glutamate-induced excitotoxic death (Lee et al, 2006) and alleviate status epilepticus-induced neuronal damage in the hippocampus of rats (Ryu et al, 2010). Furthermore, enhancement of both type 1 and 2 interferons limits inflammation and disease progression in models of multiple sclerosis (Lin et al, 2007;Bowen and Olson, 2013;Naves et al, 2013).…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, the kynurenine pathway can be activated by the release of proinflammatory cytokines, which have been implicated in the pathophysiology of epilepsy, especially in the context of cortical dysplasia and glioneuronal tumors [4143]. Several cytokines, including IFN-γ, are stimulated by seizures and serve as inducers of IDO [44, 45], and they may represent a potential pharmacological target for treatment of epileptogenic lesions.…”
Section: Discussionmentioning
confidence: 99%
“…The pump was placed in a subcutaneous pocket in the dorsal region. Animals received 0.5 μl/hr of vehicle or compound for 1 week [39-41]. Therefore, the doses of BzATP, OxATP and IL-1Ra were 43 μg, 30 μg and 0.06 μg/day per animal, respectively.…”
Section: Methodsmentioning
confidence: 99%